Breeding Buckwheat for Increased Levels of Rutin, Quercetin and Other Bioactive Compounds with Potential Antiviral Effects.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing agricultural and mechanistic findings without original human data.
PubMed 33255469 · doi:10.3390/plants9121638
What was done
The authors reviewed the distribution and degradation pathways of bioactive compounds (including rutin, quercetin, emodin, and fagopyrin) in common buckwheat (*Fagopyrum esculentum*) and Tartary buckwheat (*Fagopyrum tataricum*). They evaluated agricultural and breeding strategies, including selecting for low rutinosidase activity and larger grain embryos, aimed at optimizing flavonoid content for functional food applications.
What was found
The abstract reports qualitative mechanisms without quantitative numerical data. Rutin in damaged or milled wet grain is degraded to quercetin by rutinosidase. Tartary buckwheat varieties with low rutinosidase activity preserve original grain rutin levels in prepared foods. Quercetin from rutin degradation contributes to intestinal α-glucosidase inhibition, and rutin and emodin have potential antiviral effects. Because grain embryos are rich in rutin, breeding for larger embryos represents a strategy to increase overall grain rutin content.
Why it matters
This review identifies specific biochemical targets and breeding approaches—such as embryo enlargement and rutinosidase inhibition—to produce buckwheat cultivars with enhanced nutritional profiles.
Limits
The abstract provides no numerical measurements, sample sizes, or statistical comparisons. Suggested health benefits (such as antiviral activity and glycemic control) are based on mechanistic reasoning rather than direct clinical trial evidence.
Cited by
- supports Himalayan Tartary buckwheat contains over 100 immune-active polyphenols, including quercetin and rutin.